Message Title

Message Explanation

Join the discussion!

We discuss the main systemic weakness of labs during the COVID-19 pandemic. What do the vendors have to say?


29 April 2020


10am USA CST
12pm Brazil
5pm Germany
5pm SA
11am Chile



1. What have been the main challenges in getting new instrumentation, test kits and consumables to customers?
2. What changes are being implemented in your business to mitigate these challenges in future? 


PPedro Di Rocco: General Director - BioMérieux Iberia (Spain and Portugal)
Ernie Loynaz: VP Commercial Operations, Latin America - Ortho Clinical Diagnostics
Andre Pacheco: Procurement and Business Development Director - Cremer- Mafra Group 
Patrick Murray: VP, WW Scientific Affairs - BD Life Sciences 
Susan Sharp: Scientfic Director COPAN Diagnostics, Inc.